USANA Health Sciences, Inc. (USNA) Insider Trading Activity
NYSE$29.21
Market Cap
$543.98M
Sector
Consumer Defensive
Industry
Packaged Foods
Rank in Sector
151 of 157
Rank in Industry
44 of 44
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
| $121M | ||
| $34M | ||
| $21M | ||
| $14M | ||
| $10M | ||
| $5M |
USNA Insider Trading Activity
USNA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $2,170,446 | 17 | 100 |
Related Transactions
| Pelosi Peggie | director | 0 | $0 | 1 | $21,918 | $-21,918 |
| Fleming John Turman | director | 0 | $0 | 2 | $61,078 | $-61,078 |
| FULLER GILBERT A | director | 0 | $0 | 4 | $93,502 | $-93,502 |
| Mulham David Mulham | CHIEF SALES OFFICER | 0 | $0 | 1 | $106,670 | $-106,670 |
| IIEKKING G DOUG | CHIEF FINANCIAL OFFICER | 0 | $0 | 1 | $134,662 | $-134,662 |
| Brown Jim | CEO & PRESIDENT | 0 | $0 | 1 | $147,350 | $-147,350 |
| Neidig Brent | CHIEF COMMERCIAL OFFICER | 0 | $0 | 1 | $153,387 | $-153,387 |
| Foukas Joshua | CHIEF LEGAL OFFICER | 0 | $0 | 1 | $186,514 | $-186,514 |
| Jones Paul A. | CHIEF PEOPLE OFFICER | 0 | $0 | 2 | $372,550 | $-372,550 |
| WENTZ MYRON W | 10 percent owner | 0 | $0 | 3 | $892,815 | $-892,815 |
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Insider Activity of USANA Health Sciences, Inc.
Over the last 12 months, insiders at USANA Health Sciences, Inc. have bought $0 and sold $2.17M worth of USANA Health Sciences, Inc. stock.
On average, over the past 5 years, insiders at USANA Health Sciences, Inc. have bought $0 and sold $23.29M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,792 shares for transaction amount of $1.47M was made by WENTZ MYRON W (director) on 2017‑12‑11.
List of Insider Buy and Sell Transactions, USANA Health Sciences, Inc.
| 2025-05-09 | Sale | IIEKKING G DOUG | CHIEF FINANCIAL OFFICER | 4,548 0.0245% | $29.61 | $134,662 | -0.24% | |
| 2025-05-05 | Sale | FULLER GILBERT A | director | 674 0.0037% | $29.82 | $20,101 | +1.38% | |
| 2025-03-12 | Sale | Neidig Brent | CHIEF COMMERCIAL OFFICER | 4,743 0.0248% | $32.34 | $153,387 | -16.07% | |
| 2025-03-12 | Sale | Foukas Joshua | CHIEF LEGAL OFFICER | 5,732 0.0301% | $32.54 | $186,514 | -16.07% | |
| 2025-03-11 | Sale | Fleming John Turman | director | 500 0.0026% | $33.30 | $16,648 | -17.52% | |
| 2025-03-10 | Sale | Mulham David Mulham | CHIEF SALES OFFICER | 3,234 0.0169% | $32.98 | $106,670 | -17.44% | |
| 2025-03-06 | Sale | FULLER GILBERT A | director | 674 0.0034% | $31.44 | $21,190 | -15.59% | |
| 2025-03-03 | Sale | Brown Jim | CEO & PRESIDENT | 5,000 0.0261% | $29.47 | $147,350 | -8.14% | |
| 2025-02-27 | Sale | Pelosi Peggie | director | 780 0.0041% | $28.10 | $21,918 | -3.35% | |
| 2024-11-04 | Sale | FULLER GILBERT A | director | 675 0.0035% | $37.71 | $25,457 | -14.27% | |
| 2024-08-13 | Sale | Jones Paul A. | CHIEF PEOPLE OFFICER | 6,266 0.0338% | $38.38 | $240,487 | -8.70% | |
| 2024-08-07 | Sale | FULLER GILBERT A | director | 674 0.0035% | $39.69 | $26,753 | -10.92% | |
| 2024-07-31 | Sale | Fleming John Turman | director | 1,000 0.0053% | $44.43 | $44,430 | -20.49% | |
| 2024-06-14 | Sale | WENTZ MYRON W | 10 percent owner | 13,496 0.0676% | $45.03 | $607,725 | -19.06% | |
| 2024-06-12 | Sale | WENTZ MYRON W | 10 percent owner | 2,202 0.0117% | $47.79 | $105,234 | -21.04% | |
| 2024-06-07 | Sale | WENTZ MYRON W | 10 percent owner | 3,700 0.0199% | $48.61 | $179,857 | -22.96% | |
| 2024-05-22 | Sale | Jones Paul A. | CHIEF PEOPLE OFFICER | 2,714 0.0143% | $48.66 | $132,064 | -24.27% | |
| 2024-05-07 | Sale | IIEKKING G DOUG | CHIEF FINANCIAL OFFICER | 5,198 0.0271% | $44.76 | $232,677 | -16.54% | |
| 2024-05-07 | Sale | FULLER GILBERT A | director | 490 0.0025% | $44.59 | $21,849 | -16.54% | |
| 2024-05-02 | Sale | Macuga Daniel A. | CHIEF COMMUNICATIONS OFFICER | 3,791 0.0197% | $47.14 | $178,717 | -20.04% |
Total: 978
*Gray background shows transactions not older than one year
Insider Historical Profitability
11.89%
| WENTZ MYRON W | 10 percent owner | 7864345 42.229% | $229.72M | 16 | 215 | +9.06% |
| Brown Jim | CEO & PRESIDENT | 15716 0.0844% | $459,064.36 | 0 | 20 | |
| Mulham David Mulham | CHIEF SALES OFFICER | 12775 0.0686% | $373,157.75 | 0 | 17 | |
| Fleming John Turman | director | 4026 0.0216% | $117,599.46 | 0 | 6 | |
| Pelosi Peggie | director | 3395 0.0182% | $99,167.95 | 0 | 2 | |
| FULLER GILBERT A | director | 0 0% | $0 | 0 | 50 | |
| IIEKKING G DOUG | CHIEF FINANCIAL OFFICER | 0 0% | $0 | 0 | 23 | |
| Jones Paul A. | CHIEF PEOPLE OFFICER | 0 0% | $0 | 0 | 20 | |
| Foukas Joshua | CHIEF LEGAL OFFICER | 0 0% | $0 | 0 | 17 | |
| Neidig Brent | CHIEF COMMERCIAL OFFICER | 0 0% | $0 | 0 | 12 | |
| Gull Global Ltd | 10 percent owner | 9865614 52.9751% | $288.17M | 4 | 105 | +57.15% |
| GULL HOLDINGS LTD | 10 percent owner | 6574167 35.3011% | $192.03M | 12 | 83 | <0.0001% |
| WENTZ DAVE | Co-C.E.O. | 384883 2.0667% | $11.24M | 3 | 63 | +24.33% |
| Guest Kevin | EXEC. CHAIRMAN OF THE BOARD | 10491 0.0563% | $306,442.11 | 0 | 37 | |
| WILSON MARK H | E.V.P. of Sales | 5000 0.0268% | $146,050.00 | 0 | 19 | |
| Bramble James | Chief Legal Officer and Sec | 2076 0.0111% | $60,639.96 | 1 | 16 | +65.07% |
| Winssinger Frederic J | director | 1703 0.0091% | $49,744.63 | 0 | 7 | |
| Woo Deborah | President of Asia | 1479 0.0079% | $43,201.59 | 0 | 28 | |
| Ding Xia | director | 1421 0.0076% | $41,507.41 | 0 | 1 | |
| Nixon J Scott | director | 924 0.005% | $26,990.04 | 0 | 1 | |
| Peng Feng | director | 329 0.0018% | $9,610.09 | 0 | 8 | |
| AUCIAUX ROBERT | director | 298 0.0016% | $8,704.58 | 0 | 20 | |
| MCCLAIN JERRY G | director | 0 0% | $0 | 0 | 31 | |
| WAITLEY DENIS E | director | 0 0% | $0 | 0 | 7 | |
| POELMAN RONALD S | director | 0 0% | $0 | 0 | 12 | |
| WOOD TIMOTHY E | director | 0 0% | $0 | 0 | 15 | |
| COOPER FRED W | President and COO | 0 0% | $0 | 0 | 19 | |
| SINNOTT ROBERT A | CHIEF SCIENTIFIC OFFICER | 0 0% | $0 | 0 | 12 | |
| Richardson Bradford | E.V.P. of Asia Pacific | 0 0% | $0 | 0 | 19 | |
| Truett Roy | Chief Operating Officer | 0 0% | $0 | 0 | 3 | |
| Yates Jeffrey | Chief Financial Officer | 0 0% | $0 | 0 | 1 | |
| Braun Doug | Chief Marketing Officer | 0 0% | $0 | 0 | 5 | |
| Macuga Daniel A. | CHIEF COMMUNICATIONS OFFICER | 0 0% | $0 | 0 | 29 | |
| Stambaugh Rick | Chief Information Officer | 0 0% | $0 | 0 | 3 | |
| Noot Walter | CHIEF OPERATING OFFICER | 0 0% | $0 | 0 | 16 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
$45,235,911 | 167 | 3.36% | $262.97M | |
$541,955,018 | 140 | 11.36% | $148.92M | |
$933,767,251 | 102 | 19.01% | $683.39M | |
$101,983,535 | 96 | 25.36% | $725.23M | |
$5,911,305 | 69 | 23.60% | $158.11M | |
USANA Health Sciences, Inc. (USNA) | $15,487,425 | 36 | 11.89% | $543.98M |
$12,547,410 | 36 | 6.32% | $2B | |
$4,771,903 | 34 | 15.14% | $339.94M | |
$73,529,691 | 32 | 0.46% | $699.4M | |
$28,922,382 | 28 | 23.46% | $719.05M | |
$1,680,244 | 27 | 10.94% | $610.1M | |
$32,609,414 | 27 | 37.83% | $337.05M | |
$9,394,630 | 27 | 7.33% | $1.11B | |
$2,214,250 | 23 | 13.92% | $1.08B | |
$2,253,451 | 11 | -7.28% | $144.8M | |
$4,268,668 | 8 | 20.05% | $77.84M | |
$21,483 | 8 | -1.62% | $71.48M | |
$2,912,100 | 7 | 43.17% | $188.88M | |
$999,094 | 1 | 65.99% | $1.49B |
USNA Institutional Investors: Active Positions
| Increased Positions | 74 | +46.25% | 630,439 | +5.94% |
| Decreased Positions | 66 | -41.25% | 1M | -10.03% |
| New Positions | 23 | New | 188,343 | New |
| Sold Out Positions | 19 | Sold Out | 110,220 | Sold Out |
| Total Postitions | 168 | +5% | 10M | -4.09% |
USNA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $54,138.00 | 9.68% | 1.84M | -3,162 | -0.17% | 2025-03-31 |
| Vanguard Group Inc | $45,535.00 | 8.14% | 1.55M | -55,795 | -3.48% | 2024-12-31 |
| Pzena Investment Management Llc | $32,242.00 | 5.76% | 1.1M | +8,110 | +0.75% | 2025-03-31 |
| Renaissance Technologies Llc | $32,115.00 | 5.74% | 1.09M | -58,400 | -5.08% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $22,764.00 | 4.07% | 773,228 | +55,059 | +7.67% | 2024-12-31 |
| Pacer Advisors, Inc. | $17,429.00 | 3.12% | 592,001 | +47,745 | +8.77% | 2024-12-31 |
| State Street Corp | $13,283.00 | 2.38% | 451,193 | +16,029 | +3.68% | 2024-12-31 |
| Geode Capital Management, Llc | $8,889.00 | 1.59% | 301,949 | +4,829 | +1.63% | 2024-12-31 |
| American Century Companies Inc | $6,883.00 | 1.23% | 233,797 | +25,522 | +12.25% | 2024-12-31 |
| D. E. Shaw & Co., Inc. | $6,117.00 | 1.09% | 207,784 | -2 | <0.01% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Price to Earnings
Price/Earnings to Growth
Price to Sales
Price to Book
Price/Free Cash Flow
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.